These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 1703607
1. UK-52,046 (a novel alpha 1-adrenoceptor antagonist) and the role of alpha-adrenoceptor stimulation and blockade on atrioventricular conduction. Spiers JP, Harron DW, Wilson R, Allen JD. J Cardiovasc Pharmacol; 1990 Nov; 16(5):824-30. PubMed ID: 1703607 [Abstract] [Full Text] [Related]
2. Effect of UK-52,046, an alpha 1-adrenoceptor antagonist, on baroreflex function in man. McKaigue JP, Harron DW. Br J Clin Pharmacol; 1990 Oct; 30(4):579-84. PubMed ID: 1981319 [Abstract] [Full Text] [Related]
3. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects. Schafers RF, Elliott HL, Howie CA, Reid JL. Br J Clin Pharmacol; 1991 Nov; 32(5):599-604. PubMed ID: 1683249 [Abstract] [Full Text] [Related]
4. Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man. Tham TC, Guy S, Shanks RG, Harron DW. Br J Clin Pharmacol; 1992 Apr; 33(4):405-9. PubMed ID: 1349492 [Abstract] [Full Text] [Related]
5. Duration of action and effect on baroreflex function of the anti-arrhythmic alpha 1 antagonist UK-52,046. Spiers JP, Harron DW, Wilson R. J Pharm Pharmacol; 1991 Jan; 43(1):70-2. PubMed ID: 1676070 [Abstract] [Full Text] [Related]
6. Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs. Imagawa J, Nabata H, Sakai K. Jpn J Pharmacol; 1987 May; 44(1):35-41. PubMed ID: 2887683 [Abstract] [Full Text] [Related]
7. The role of alpha 1- and alpha 2-adrenoceptors in canine systemic capacitance vessels--a study with measurement of mean circulatory pressure. Hirose I, Ito H, Nagata K, Sahashi T, Wada H, Takai K, Hirakawa S. Jpn Circ J; 1990 Feb; 54(2):152-60. PubMed ID: 1972411 [Abstract] [Full Text] [Related]
8. Alpha adrenoceptor blockade with oral prazosin. Pitterman AB, Rollins DE, Shen DD, Hurwitz A, Hassanein KM. Clin Pharmacol Ther; 1981 Feb; 29(2):143-8. PubMed ID: 6109587 [Abstract] [Full Text] [Related]
9. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs. Uprichard AG, Harron DW, Wilson R, Shanks RG. Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912 [Abstract] [Full Text] [Related]
10. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers. Riva E, Mennini T, Latini R. Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367 [Abstract] [Full Text] [Related]
11. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs. Shebuski RJ, Zimmerman BG. J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276 [Abstract] [Full Text] [Related]
12. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors. Dunn WR, McGrath JC, Wilson VG. Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360 [Abstract] [Full Text] [Related]
13. Role of alpha 1- and alpha 2-adrenoceptors in the modulation of the baroreflex vagal bradycardia. Huchet AM, Chelly J, Schmitt H. Eur J Pharmacol; 1981 May 22; 71(4):455-61. PubMed ID: 6113971 [Abstract] [Full Text] [Related]
14. Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs. Shibasaki M, Sudoh K, Inagaki O, Uchida W, Honda K. J Auton Pharmacol; 1992 Aug 22; 12(4):263-8. PubMed ID: 1355094 [Abstract] [Full Text] [Related]
15. The role of alpha-adrenoceptors in the regulation of renal tubular sodium reabsorption and renin secretion in the rabbit. Hesse IF, Johns EJ. Br J Pharmacol; 1985 Mar 22; 84(3):715-24. PubMed ID: 2859065 [Abstract] [Full Text] [Related]
16. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects. Schafers RF, Elliott HL, Meredith PA, Miller SH, Reid JL. Br J Clin Pharmacol; 1991 Nov 22; 32(5):605-10. PubMed ID: 1683250 [Abstract] [Full Text] [Related]
18. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries. Kopia GA, Kopaciewicz LJ, Ruffolo RR. J Pharmacol Exp Ther; 1986 Dec 22; 239(3):641-7. PubMed ID: 2879028 [Abstract] [Full Text] [Related]
19. Vasoactive intestinal peptide: electrophysiologic activity in the newborn heart. Pickoff AS, Wang SN, Stolfi A, Ramage D, Ross-Ascuitto NT, Kydon DW, Ascuitto RJ. Pediatr Res; 1994 Feb 22; 35(2):244-9. PubMed ID: 8165061 [Abstract] [Full Text] [Related]
20. Effect of tamsulosin, a novel alpha 1-adrenoceptor antagonist, on urethral pressure profile in anaesthetized dogs. Sudoh K, Tanaka H, Inagaki O, Asano M, Takenaka T. J Auton Pharmacol; 1996 Jun 22; 16(3):147-54. PubMed ID: 8884461 [Abstract] [Full Text] [Related] Page: [Next] [New Search]